GlassScriptPhysician profile
Sheila Bird
NPI 1780111377
$4,486.14
in general payments reported to CMS, 2019-2025
24 companies · $694 in 2025
The $694 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $984 · 2022: $990 · 2023: $1,392 · 2024: $425 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,511.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $991.71 | 2021-2024 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $556.95 | 2021-2025 | Farxiga, Brilinta, Wainua |
| Boston Scientific Corporation | $539.75 | 2021-2025 | Watchman Access System |
| Amgen INC. | $433.65 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $245.86 | 2021-2025 | Camzyos, Eliquis |
| Abiomed | $239.98 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $220.75 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.20 | 2021-2025 | Lifevest |
| Pfizer INC. | $176.33 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.09 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $121.74 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $118.83 | 2021-2024 | Xarelto |
| Biosense Webster, INC. | $79.40 | 2021-2024 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $78.22 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $61.13 | 2022-2023 | Verquvo, Steglatro |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $57.83 | 2021-2022 | |
| Medtronic, INC. | $46.72 | 2023 | Micra, Selectsecure, Azure Xt Dr Mri Surescan |
| Medicomp INC | $39.52 | 2025 | Telepatch Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $30.56 | 2023 | |
| W. L. Gore & Associates, INC. | $26.23 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Daiichi Sankyo INC. | $26.09 | 2021 | |
| Atricure, INC. | $25.33 | 2022 | |
| Abbott Laboratories | $24.30 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $20.97 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Bird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.